Preparatory Work to Support the Risk Assessment for Peri- and Postmenopausal Women Taking Food Supplements Containing Isolated Isoflavones

    October 2015 in “ EFSA supporting publications
    Marja Tijhuis, Esmée L. Doets, Vera van der Velpen, Marije Vonk Noordegraaf‐Schouten
    TLDR Isoflavones may help with menopause symptoms but could be risky for women with hormone-sensitive cancers.
    The document detailed preparatory work for assessing the risks associated with peri- and postmenopausal women taking food supplements containing isolated isoflavones. Conducted by researchers from Pallas Health Research and Consultancy and Wageningen University, the study was commissioned by the European Food Safety Authority. The report aimed to ensure transparency and was not an official output of the Authority. The findings contributed to understanding the safety and potential health impacts of isoflavone supplements in the specified demographic.
    Discuss this study in the Community →

    Cited in this study

    1 / 1 results

    Related

    1 / 1 results